CELSO
ARANGO LÓPEZ
Catedrático de universidad
Publicaciones en las que colabora con CELSO ARANGO LÓPEZ (11)
2021
-
Humanization in mental health plans in Spain
Revista de Psiquiatria y Salud Mental
2019
-
CIBERSAM: Ten years of collaborative translational research in mental disorders
Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 1, pp. 1-8
2018
-
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study
The Lancet Psychiatry, Vol. 5, Núm. 10, pp. 797-807
-
Personality organization and its association with clinical and functional features in borderline personality disorder
Psychiatry Research, Vol. 262, pp. 393-399
2017
-
Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics
Frontiers in Neuroendocrinology, Vol. 45, pp. 25-34
2016
-
Consenso español sobre los riesgos y detección de la hiperprolactinemia iatrogénica por antipsicóticos
Revista de Psiquiatria y Salud Mental
2015
-
Desarrollo profesional en investigación traslacional en neurociencias y salud mental: educación y formación dentro del Centro de Investigación Biomédica en Red en Salud Mental
Revista de Psiquiatria y Salud Mental, Vol. 8, Núm. 2, pp. 65-74
2014
-
Replication of previous genome-wide association studies of psychiatric diseases in a large schizophrenia case-control sample from Spain
Schizophrenia Research, Vol. 159, Núm. 1, pp. 107-113
2012
-
Psychometric properties of the Spanish version of the Diagnostic Interview for Depressive Personality
European Psychiatry, Vol. 27, Núm. 8, pp. 582-590
2006
-
Negative signs and symptoms secondary to antipsychotics: A double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers
American Journal of Psychiatry, Vol. 163, Núm. 3, pp. 488-493
2002
-
Association between relative temporal and prefrontal sulcal cerebrospinal fluid and illness duration in schizophrenia
Schizophrenia Research, Vol. 58, Núm. 2-3, pp. 305-312